Review



human idh2 dna plasmid  (OriGene)


Bioz Verified Symbol OriGene is a verified supplier
Bioz Manufacturer Symbol OriGene manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    OriGene human idh2 dna plasmid
    Human Idh2 Dna Plasmid, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 8 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human idh2 dna plasmid/product/OriGene
    Average 90 stars, based on 8 article reviews
    human idh2 dna plasmid - by Bioz Stars, 2026-02
    90/100 stars

    Images



    Similar Products

    90
    OriGene human idh2 dna plasmid
    Human Idh2 Dna Plasmid, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human idh2 dna plasmid/product/OriGene
    Average 90 stars, based on 1 article reviews
    human idh2 dna plasmid - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    OriGene human idh2 dna plasmid clone nm_002168 pcmv6ac_idh2
    Human Idh2 Dna Plasmid Clone Nm 002168 Pcmv6ac Idh2, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human idh2 dna plasmid clone nm_002168 pcmv6ac_idh2/product/OriGene
    Average 90 stars, based on 1 article reviews
    human idh2 dna plasmid clone nm_002168 pcmv6ac_idh2 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    OriGene nm 002168 dna plasmid
    Differences in global DNA 5hmC (5-hydroxymethylcytosine) levels, TET (ten-eleven translocation) activity, α-ketoglutarate (α-KG) levels, and mRNA levels of <t>IDH2</t> (isocitrate dehydrogenase 2) between nonasthmatic and asthmatic airway smooth muscle (ASM) cells. (A and B) Global DNA 5hmC levels (A) and TET activity (B) in asthmatic ASM cells relative to nonasthmatic cells were assayed by ELISA. (C) α-KG levels in cells were assayed by a coupled enzyme assay. (D) mRNA levels of IDH2 were assayed by quantitative PCR (qPCR). Each data point represents an individual lung donor. Values are mean ± SEM (six lung donors without asthma and six with asthma). *P < 0.05, **P < 0.01, and ***P < 0.001 in comparison with nonasthmatic ASM cells.
    Nm 002168 Dna Plasmid, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nm 002168 dna plasmid/product/OriGene
    Average 90 stars, based on 1 article reviews
    nm 002168 dna plasmid - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    Image Search Results


    Differences in global DNA 5hmC (5-hydroxymethylcytosine) levels, TET (ten-eleven translocation) activity, α-ketoglutarate (α-KG) levels, and mRNA levels of IDH2 (isocitrate dehydrogenase 2) between nonasthmatic and asthmatic airway smooth muscle (ASM) cells. (A and B) Global DNA 5hmC levels (A) and TET activity (B) in asthmatic ASM cells relative to nonasthmatic cells were assayed by ELISA. (C) α-KG levels in cells were assayed by a coupled enzyme assay. (D) mRNA levels of IDH2 were assayed by quantitative PCR (qPCR). Each data point represents an individual lung donor. Values are mean ± SEM (six lung donors without asthma and six with asthma). *P < 0.05, **P < 0.01, and ***P < 0.001 in comparison with nonasthmatic ASM cells.

    Journal: American Journal of Respiratory Cell and Molecular Biology

    Article Title: Role of Isocitrate Dehydrogenase 2 on DNA Hydroxymethylation in Human Airway Smooth Muscle Cells

    doi: 10.1165/rcmb.2019-0323OC

    Figure Lengend Snippet: Differences in global DNA 5hmC (5-hydroxymethylcytosine) levels, TET (ten-eleven translocation) activity, α-ketoglutarate (α-KG) levels, and mRNA levels of IDH2 (isocitrate dehydrogenase 2) between nonasthmatic and asthmatic airway smooth muscle (ASM) cells. (A and B) Global DNA 5hmC levels (A) and TET activity (B) in asthmatic ASM cells relative to nonasthmatic cells were assayed by ELISA. (C) α-KG levels in cells were assayed by a coupled enzyme assay. (D) mRNA levels of IDH2 were assayed by quantitative PCR (qPCR). Each data point represents an individual lung donor. Values are mean ± SEM (six lung donors without asthma and six with asthma). *P < 0.05, **P < 0.01, and ***P < 0.001 in comparison with nonasthmatic ASM cells.

    Article Snippet: Alternatively, the cells were transfected with 500 ng of IDH2 ( {"type":"entrez-nucleotide","attrs":{"text":"NM_002168","term_id":"1780222522","term_text":"NM_002168"}} NM_002168 ) DNA plasmid (pCMV6-AC_IDH2, ORIGENE SC319226) or an empty vector (pCMV6-AC, ORIGENE PS100020) for IDH2 overexpression.

    Techniques: Translocation Assay, Activity Assay, Enzyme-linked Immunosorbent Assay, Enzymatic Assay, Real-time Polymerase Chain Reaction

    Knockdown of IDH2 by siIDH2 (siRNA against IDH2) decreased gene expression of IDH2, α-KG levels, TET activity, and global 5hmC levels in human asthmatic ASM cells. (A) mRNA levels of IDH2 were assayed by qPCR. (B) α-KG levels in cells were assayed by a coupled enzyme assay. (C and D) TET activity (C) and global 5hmC levels (D) were examined by ELISA. Each data point represents an individual lung donor. (A–C) All data are represented as the percentage change relative to lipofectamine (LF) controls and shown as mean values ± SEM (six lung donors with asthma). (D) Absolute amount of 5hmC in genomic DNA are present. *P < 0.05 and ****P < 0.0001 in comparison with siCTL (scramble siRNA control)-treated asthmatic ASM cells.

    Journal: American Journal of Respiratory Cell and Molecular Biology

    Article Title: Role of Isocitrate Dehydrogenase 2 on DNA Hydroxymethylation in Human Airway Smooth Muscle Cells

    doi: 10.1165/rcmb.2019-0323OC

    Figure Lengend Snippet: Knockdown of IDH2 by siIDH2 (siRNA against IDH2) decreased gene expression of IDH2, α-KG levels, TET activity, and global 5hmC levels in human asthmatic ASM cells. (A) mRNA levels of IDH2 were assayed by qPCR. (B) α-KG levels in cells were assayed by a coupled enzyme assay. (C and D) TET activity (C) and global 5hmC levels (D) were examined by ELISA. Each data point represents an individual lung donor. (A–C) All data are represented as the percentage change relative to lipofectamine (LF) controls and shown as mean values ± SEM (six lung donors with asthma). (D) Absolute amount of 5hmC in genomic DNA are present. *P < 0.05 and ****P < 0.0001 in comparison with siCTL (scramble siRNA control)-treated asthmatic ASM cells.

    Article Snippet: Alternatively, the cells were transfected with 500 ng of IDH2 ( {"type":"entrez-nucleotide","attrs":{"text":"NM_002168","term_id":"1780222522","term_text":"NM_002168"}} NM_002168 ) DNA plasmid (pCMV6-AC_IDH2, ORIGENE SC319226) or an empty vector (pCMV6-AC, ORIGENE PS100020) for IDH2 overexpression.

    Techniques: Expressing, Activity Assay, Enzymatic Assay, Enzyme-linked Immunosorbent Assay

    Knockdown of IDH2 by siIDH2 reduced TGFB2 (transforming growth factor-β2) mRNA levels and hydroxymethylation of the TGFB2 promoter in human asthmatic ASM cells. (A) mRNA levels of TGFB2 in samples were assayed by qPCR. (B) Schematic diagram of CpG dinucleotide (GC) content (percentage) in the 5′ promoter region of TGFB2. In silico analysis identified the CpG islands (shaded in gray in the genomic DNA sequence) based on a GC content > 60% with an observed/expected ratio of 0.6 (MethPrimer). The PCR amplicon generated by PCR is indicated by the regions bounded by arrows. (C) Average of TGFB2 promoter methylation in nonasthmatic and asthmatic ASM cells was assayed by bisulfite sequencing. (D) mRNA levels of TGFB2 in asthmatic ASM cells after siRNA treatment were assayed by qPCR. (E and F) The average percentage of methylation (E) and hydroxymethylation (F) of each CpG site of the TGFB2 promoter in asthmatic ASM cells (six donors) was assayed by oxidative bisulfite sequencing. Four to six individual clones from each donor were picked for sequencing. Each data point represents the mean of six donors in LF controls (solid circles) and siCTL-treated (solid squares) and siIDH2-treated (open triangles) asthmatic ASM cells. *P < 0.05, **P < 0.01, and ***P < 0.001 compared with LF controls. #P = 0.05 compared with siCTL-transfected cells. ATG = translation start site; Ave. = average; TSS = transcription start site; UTR = untranslated region.

    Journal: American Journal of Respiratory Cell and Molecular Biology

    Article Title: Role of Isocitrate Dehydrogenase 2 on DNA Hydroxymethylation in Human Airway Smooth Muscle Cells

    doi: 10.1165/rcmb.2019-0323OC

    Figure Lengend Snippet: Knockdown of IDH2 by siIDH2 reduced TGFB2 (transforming growth factor-β2) mRNA levels and hydroxymethylation of the TGFB2 promoter in human asthmatic ASM cells. (A) mRNA levels of TGFB2 in samples were assayed by qPCR. (B) Schematic diagram of CpG dinucleotide (GC) content (percentage) in the 5′ promoter region of TGFB2. In silico analysis identified the CpG islands (shaded in gray in the genomic DNA sequence) based on a GC content > 60% with an observed/expected ratio of 0.6 (MethPrimer). The PCR amplicon generated by PCR is indicated by the regions bounded by arrows. (C) Average of TGFB2 promoter methylation in nonasthmatic and asthmatic ASM cells was assayed by bisulfite sequencing. (D) mRNA levels of TGFB2 in asthmatic ASM cells after siRNA treatment were assayed by qPCR. (E and F) The average percentage of methylation (E) and hydroxymethylation (F) of each CpG site of the TGFB2 promoter in asthmatic ASM cells (six donors) was assayed by oxidative bisulfite sequencing. Four to six individual clones from each donor were picked for sequencing. Each data point represents the mean of six donors in LF controls (solid circles) and siCTL-treated (solid squares) and siIDH2-treated (open triangles) asthmatic ASM cells. *P < 0.05, **P < 0.01, and ***P < 0.001 compared with LF controls. #P = 0.05 compared with siCTL-transfected cells. ATG = translation start site; Ave. = average; TSS = transcription start site; UTR = untranslated region.

    Article Snippet: Alternatively, the cells were transfected with 500 ng of IDH2 ( {"type":"entrez-nucleotide","attrs":{"text":"NM_002168","term_id":"1780222522","term_text":"NM_002168"}} NM_002168 ) DNA plasmid (pCMV6-AC_IDH2, ORIGENE SC319226) or an empty vector (pCMV6-AC, ORIGENE PS100020) for IDH2 overexpression.

    Techniques: In Silico, Sequencing, Amplification, Generated, Methylation, Methylation Sequencing, Oxidative Bisulfite Sequencing, Clone Assay, Transfection

    Overexpression of IDH2 showed increased α-KG levels and TET activity in human nonasthmatic ASM cells. (A) mRNA levels of IDH2 were assayed by qPCR. (B) α-KG levels in cells were assayed by a coupled enzyme assay. (C and D) TET activity (C) and global 5hmC levels (D) were examined by ELISA. Each data point represents an individual lung donor. All data are represented as the percentage change relative to LF controls and shown as mean values ± SEM (four lung donors without asthma). *P < 0.05 compared with pCMV6-transfected ASM cells.

    Journal: American Journal of Respiratory Cell and Molecular Biology

    Article Title: Role of Isocitrate Dehydrogenase 2 on DNA Hydroxymethylation in Human Airway Smooth Muscle Cells

    doi: 10.1165/rcmb.2019-0323OC

    Figure Lengend Snippet: Overexpression of IDH2 showed increased α-KG levels and TET activity in human nonasthmatic ASM cells. (A) mRNA levels of IDH2 were assayed by qPCR. (B) α-KG levels in cells were assayed by a coupled enzyme assay. (C and D) TET activity (C) and global 5hmC levels (D) were examined by ELISA. Each data point represents an individual lung donor. All data are represented as the percentage change relative to LF controls and shown as mean values ± SEM (four lung donors without asthma). *P < 0.05 compared with pCMV6-transfected ASM cells.

    Article Snippet: Alternatively, the cells were transfected with 500 ng of IDH2 ( {"type":"entrez-nucleotide","attrs":{"text":"NM_002168","term_id":"1780222522","term_text":"NM_002168"}} NM_002168 ) DNA plasmid (pCMV6-AC_IDH2, ORIGENE SC319226) or an empty vector (pCMV6-AC, ORIGENE PS100020) for IDH2 overexpression.

    Techniques: Over Expression, Activity Assay, Enzymatic Assay, Enzyme-linked Immunosorbent Assay, Transfection

    Overexpression of  IDH2  Altered Airway Smooth Muscle Phenotypic Gene Expression in Human Nonasthmatic Airway Smooth Muscle Cells

    Journal: American Journal of Respiratory Cell and Molecular Biology

    Article Title: Role of Isocitrate Dehydrogenase 2 on DNA Hydroxymethylation in Human Airway Smooth Muscle Cells

    doi: 10.1165/rcmb.2019-0323OC

    Figure Lengend Snippet: Overexpression of IDH2 Altered Airway Smooth Muscle Phenotypic Gene Expression in Human Nonasthmatic Airway Smooth Muscle Cells

    Article Snippet: Alternatively, the cells were transfected with 500 ng of IDH2 ( {"type":"entrez-nucleotide","attrs":{"text":"NM_002168","term_id":"1780222522","term_text":"NM_002168"}} NM_002168 ) DNA plasmid (pCMV6-AC_IDH2, ORIGENE SC319226) or an empty vector (pCMV6-AC, ORIGENE PS100020) for IDH2 overexpression.

    Techniques: Over Expression, Expressing

    Overexpression of  IDH2  Altered 5hmC Enrichment at the Gene Promoter of COL3A , SMAD3 , and TGFB2

    Journal: American Journal of Respiratory Cell and Molecular Biology

    Article Title: Role of Isocitrate Dehydrogenase 2 on DNA Hydroxymethylation in Human Airway Smooth Muscle Cells

    doi: 10.1165/rcmb.2019-0323OC

    Figure Lengend Snippet: Overexpression of IDH2 Altered 5hmC Enrichment at the Gene Promoter of COL3A , SMAD3 , and TGFB2

    Article Snippet: Alternatively, the cells were transfected with 500 ng of IDH2 ( {"type":"entrez-nucleotide","attrs":{"text":"NM_002168","term_id":"1780222522","term_text":"NM_002168"}} NM_002168 ) DNA plasmid (pCMV6-AC_IDH2, ORIGENE SC319226) or an empty vector (pCMV6-AC, ORIGENE PS100020) for IDH2 overexpression.

    Techniques: Over Expression